Botanicals Characterization In Clinical Trials Of Concern, JAMA Says
This article was originally published in The Tan Sheet
Executive Summary
Providing adequate descriptions of botanicals studied in published clinical trials is an area of concern for the Journal of the American Medical Association, the group said.